Skip to content

Clinical trials

Phase 2 Non-alcoholic Fatty Liver Disease trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Non-alcoholic Fatty Liver Disease Phase: Phase 2 Country / region: Spain Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20123
20141
20164
20173
20181
20195
20202
20216
20221
20233
20242
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Terminated10
Recruiting2
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC4
Gilead Sciences3
Novartis Pharmaceuticals3
Novo Nordisk A/S3
AstraZeneca2
Boehringer Ingelheim2
Tobira Therapeutics, Inc.2
AB Biotics, SA1
Bristol-Myers Squibb1
Celgene1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Non-alcoholic Fatty Liver Disease32
Liver Cirrhosis9
Fibrosis6
Liver Diseases4
Fatty Liver3
Digestive System Diseases2
Hypertension, Portal2
Overweight2
Ascites1
Esophageal and Gastric Varices1

Trials

Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.